MDs who are leading the Active Surveillance movement for low-risk DCIS
- Dr. Shelley Hwang, Chief of Breast Surgery, Duke Cancer Institute, Why Doctors Are Rethinking Breast-Cancer Treatment, TIME Magazine, Oct, 2015
- Dr. Ann Partridge, Founder and Director, Program for Young Women with Breast Cancer; Director, Adult Survivorship Program; Associate Professor of Medicine, Harvard Medical School Dana-Farber to study ways to reduce overtreatment of DCIS
- Dr. Alastair Thompson, Professor, Department of Breast Surgical Oncology, Division of Surgery, The University of Texas MD Anderson Cancer Center, Study seeks best way to manage breast ‘pre-cancer’
- Dr. Wen Liang, Anne Arundel Medical Center’s Rebecca Fortney Breast Center, Seeking less aggressive breast cancer treatment, Anne Arundel Medical Center takes part in clinical trial
- Dr. Laura Esserman, Director of the Breast Care Center at UCSF, A Breast Cancer Surgeon Who Keeps Challenging the Status Quo
- Dr. Susan Love, Chief visionary officer of Dr. Susan Love Research Foundation (DSLRF), DCIS Video 2016; DCIS: The Measure of the Margin
- Dr. Deanna J. Attai, Assistant Clinical Professor of Surgery at the David Geffen School of Medicine at the University of California Los Angeles, and is a Past- President of the American Society of Breast Surgeons, Active Surveillance for DCIS
DCIS Redefined 
Hello. My wife recently had a lumpectomy to remove a noninvasive DCIS. Now the doctor, who is a thoracic surgeon, wants to re-excise the area due to positive margins and follow up with radiation and tamoxifen. I and my wife really have doubts as to whether these are wise to do. Our mindset is be vigilant about it and monitor closely. Has anyone else had a similar experience that you could share?
Thank you.